DNA Sequencing Market 2024: Industry Analysis, Segments, Drivers And Trends To 2033

The new report published by The Business Research Company, titled DNA Sequencing Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the dna sequencing market size has grown rapidly in recent years. It will grow from $11.84 billion in 2023 to $13.68 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. The dna sequencing market size is expected to see rapid growth in the next few years. It will grow to $24.49 billion in 2028 at a compound annual growth rate (CAGR) of 15.7%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12604&type=smp

Surge In Cancer Cases Accelerates The Dna Sequencing Market Growth
The increasing prevalence of cancer is expected to propel the growth of the DNA sequencing market going forward. Cancer refers to uncontrolled cell growth, which impacts various organs and contributes to significant morbidity and mortality worldwide. DNA sequencing plays a crucial role in identifying genetic mutations, understanding tumor biology, and guiding treatment decisions, leading to improved outcomes in cancer care. For instance, in October 2022, Macmillan Cancer Support, the UK-based health care charity organization, there were 3 million people having cancer in 2020, and it is estimated that it will rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of the DNA sequencing market.

Industry Players Embraces Advancements In Single-Cell Dna Sequencing Technologies To Redefine The Dna Sequencing Dynamics
Advancements in single-cell DNA sequencing technologies are a key trend gaining popularity in the DNA sequencing market. Major companies operating in the DNA sequencing market are adopting new technologies to sustain their position in the market. For instance, in May 2023, Mission Bio Inc., a US-based biotechnology company, launched Tapestri v3, an advanced version of high-throughput single-cell DNA and multi-omics analysis platform. Tapestri v3 features breakthrough improvements in chemistry, significantly enhancing the detection of rare cells for various applications. With improved cell capture capabilities, researchers can now uncover deficient numbers of single cells that were previously undetectable, enabling a deeper understanding of the disease. This enhanced technology holds promise for applications like measurable residual disease (MRD) assessment in cancer, where Tapestri v3 enables the detection of relapse-driving clones that were previously missed. Additionally, it offers benefits for cell and gene therapy developers by enabling quality assessment at the single-cell level.

The dna sequencing market covered in this report is segmented -

1) By Product: Instruments, Consumables, Services
2) By Technology: Third Generation DNA Sequencing, Next-Generation Sequencing, Sanger Sequencing
3) By Application: Diagnostics, Biomarkers And Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications
1) By End User: Hospitals And Healthcare Organizations, Academics And Research Institutions, Pharmaceutical And Biotechnology Companies, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12604&type=discount

Major companies operating in the dna sequencing market report are F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics, Myriad Genetics Inc., Natera Inc., 10x Genomics Inc., GenScript Biotech Corporation, Novogene Corporation, Twist Bioscience, Genewiz LLC, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., LI-COR Inc., MGI Tech Co. Ltd., Zymo Research Corporation, Igenomix, Codex DNA, GenapSys Inc., SeqOnce Biosciences Inc.

Contents of the report:
1. Executive Summary
2. DNA Sequencing Market Report Structure
3. DNA Sequencing Market Trends And Strategies
4. DNA Sequencing Market - Macro Economic Scenario
5. DNA Sequencing Market Size And Growth
…..
27. DNA Sequencing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.